| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06919965 | A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT03390504 | A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in… | Urothelial Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05859334 | Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or… | Recurrent Glioma | Recruiting |
| NCT04917809 | A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer | Bladder Cancer | Active, Not Recruiting |
| NCT06308822 | Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With… | Advanced Lymphoma | Active, Not Recruiting |
| NCT06351371 | Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With… | Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT03155620 | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT03210714 | Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT02465060 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced… | Advanced Lymphoma | Active, Not Recruiting |
| NCT02365597 | An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With… | Urothelial Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05316155 | Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT03473743 | A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial… | Urothelial Carcinoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT04963153 | Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After… | Locally Advanced Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT05567185 | A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder… | Urinary Bladder Neoplasms | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT06204614 | Drug Screening Using IMD in Bladder Cancer | Muscle Invasive Bladder Urothelial Carcinoma | Enrolling by Invitation |